|
BR102022025291A2
(https=)
|
|
|
|
CL2025003842A1
(es)
|
|
Métodos para el tratamiento y prevención de psoriasis pustulosa generalizada (gpp).
|
|
CL2025003762A1
(es)
|
|
Formulaciones que comprenden proteína de unión al transcripto 7 similar a inmunoglobulina.
|
|
BR102023012440A2
(https=)
|
|
|
|
BR102023010976A2
(https=)
|
|
|
|
BR102023009641A2
(https=)
|
|
|
|
BR102023008688A2
(https=)
|
|
|
|
BR102023007252A2
(https=)
|
|
|
|
BR102023005164A2
(https=)
|
|
|
|
BR102023001877A2
(https=)
|
|
|
|
BR102023000289A2
(https=)
|
|
|
|
BR102022026909A2
(https=)
|
|
|
|
BY23980C1
(https=)
|
|
|
|
CN307049560S
(https=)
|
|
|
|
CN307046757S
(https=)
|
|
|
|
CN307046453S
(https=)
|
|
|
|
CN307045701S
(https=)
|
|
|
|
CN307047669S
(https=)
|
|
|
|
CN307045586S
(https=)
|
|
|
|
CN307045161S
(https=)
|
|
|
|
CN307045117S
(https=)
|
|
|
|
CN307047741S
(https=)
|
|
|
|
CN307048479S
(https=)
|
|
|
|
BY23989C1
(https=)
|
|
|
|
CN307048965S
(https=)
|
|
|